Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage
Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as t...
Gespeichert in:
Veröffentlicht in: | The American journal of pathology 2004-11, Vol.165 (5), p.1603-1612 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1612 |
---|---|
container_issue | 5 |
container_start_page | 1603 |
container_title | The American journal of pathology |
container_volume | 165 |
creator | Kawai, Hanayo Sato, Waichi Yuzawa, Yukio Kosugi, Tomoki Matsuo, Seiichi Takei, Yoshifumi Kadomatsu, Kenji Muramatsu, Takashi |
description | Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention. |
doi_str_mv | 10.1016/S0002-9440(10)63417-7 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002944010634177</els_id><sourcerecordid>15509530</sourcerecordid><originalsourceid>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</originalsourceid><addsrcrecordid>eNqFkc1uEzEURi0EomnLI4C8QcBiqO947JnZFKHQlkqpKlHYsLFu_JNxO_FE9iRV3x6niVpYsbLse77P1jEhb4F9Bgby5IYxVhZtVbGPwD5JXkFd1C_IBEQpihJaeEkmT8gBOUzpNm8lb9hrcgBCsFZwNiG_Z6jv6ODo2Fl6EYf7saPnqMch0itv7nyw9Cx0GLRN9GYdN36DPcUF-pBGOvVp1ePoQ3EZzFpbQ3_YkOffcIkLe0xeOeyTfbNfj8iv87Of0-_F7Pricvp1VmjRwliIlstGiLkzJVruGHBhmqaR85oDkygdOGxlM3ecMe00B1O1ludJ6ZyrOPIjcrrrXa3nS2u0DWPEXq2iX2J8UAN69e8k-E4tho0CCY2sq1wgdgU6DilF656ywNRWtnqUrbYmt0ePslWdc-_-vvg5tbebgfd7AJPG3sXs0adnTpa8FLLJ3Icd1_lFd--jVWmJfZ9rQeHtCqRQItOMZ_LLjrRZ6MbbqJL2Nv-OySk9KjP4_zz6D6amqdk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</creator><creatorcontrib>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</creatorcontrib><description>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</description><identifier>ISSN: 0002-9440</identifier><identifier>EISSN: 1525-2191</identifier><identifier>DOI: 10.1016/S0002-9440(10)63417-7</identifier><identifier>PMID: 15509530</identifier><identifier>CODEN: AJPAA4</identifier><language>eng</language><publisher>Bethesda, MD: Elsevier Inc</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Biological and medical sciences ; Blood Urea Nitrogen ; Blotting, Northern ; Blotting, Western ; Cell Survival ; Cisplatin - adverse effects ; Cytokines - genetics ; Cytokines - physiology ; Enzyme-Linked Immunosorbent Assay ; Fibroblasts - metabolism ; Genetic Predisposition to Disease ; In Situ Nick-End Labeling ; Inflammation ; Investigative techniques, diagnostic techniques (general aspects) ; Kidney - drug effects ; Kidney - injuries ; Kidney - pathology ; Medical sciences ; Mice ; Mice, Transgenic ; Neutrophils - metabolism ; Neutrophils - pathology ; Oligonucleotides, Antisense - chemistry ; Oligonucleotides, Antisense - pharmacology ; Original Research Paper ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Ribonucleases - metabolism ; Time Factors ; Treatment Outcome</subject><ispartof>The American journal of pathology, 2004-11, Vol.165 (5), p.1603-1612</ispartof><rights>2004 American Society for Investigative Pathology</rights><rights>2004 INIST-CNRS</rights><rights>Copyright © American Society for Investigative Pathology 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</citedby><cites>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618674/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9440(10)63417-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27903,27904,45974,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16232568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15509530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawai, Hanayo</creatorcontrib><creatorcontrib>Sato, Waichi</creatorcontrib><creatorcontrib>Yuzawa, Yukio</creatorcontrib><creatorcontrib>Kosugi, Tomoki</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Takei, Yoshifumi</creatorcontrib><creatorcontrib>Kadomatsu, Kenji</creatorcontrib><creatorcontrib>Muramatsu, Takashi</creatorcontrib><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><title>The American journal of pathology</title><addtitle>Am J Pathol</addtitle><description>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Blood Urea Nitrogen</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Cell Survival</subject><subject>Cisplatin - adverse effects</subject><subject>Cytokines - genetics</subject><subject>Cytokines - physiology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fibroblasts - metabolism</subject><subject>Genetic Predisposition to Disease</subject><subject>In Situ Nick-End Labeling</subject><subject>Inflammation</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Kidney - drug effects</subject><subject>Kidney - injuries</subject><subject>Kidney - pathology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - pathology</subject><subject>Oligonucleotides, Antisense - chemistry</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Original Research Paper</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Ribonucleases - metabolism</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0002-9440</issn><issn>1525-2191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1uEzEURi0EomnLI4C8QcBiqO947JnZFKHQlkqpKlHYsLFu_JNxO_FE9iRV3x6niVpYsbLse77P1jEhb4F9Bgby5IYxVhZtVbGPwD5JXkFd1C_IBEQpihJaeEkmT8gBOUzpNm8lb9hrcgBCsFZwNiG_Z6jv6ODo2Fl6EYf7saPnqMch0itv7nyw9Cx0GLRN9GYdN36DPcUF-pBGOvVp1ePoQ3EZzFpbQ3_YkOffcIkLe0xeOeyTfbNfj8iv87Of0-_F7Pricvp1VmjRwliIlstGiLkzJVruGHBhmqaR85oDkygdOGxlM3ecMe00B1O1ludJ6ZyrOPIjcrrrXa3nS2u0DWPEXq2iX2J8UAN69e8k-E4tho0CCY2sq1wgdgU6DilF656ywNRWtnqUrbYmt0ePslWdc-_-vvg5tbebgfd7AJPG3sXs0adnTpa8FLLJ3Icd1_lFd--jVWmJfZ9rQeHtCqRQItOMZ_LLjrRZ6MbbqJL2Nv-OySk9KjP4_zz6D6amqdk</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Kawai, Hanayo</creator><creator>Sato, Waichi</creator><creator>Yuzawa, Yukio</creator><creator>Kosugi, Tomoki</creator><creator>Matsuo, Seiichi</creator><creator>Takei, Yoshifumi</creator><creator>Kadomatsu, Kenji</creator><creator>Muramatsu, Takashi</creator><general>Elsevier Inc</general><general>ASIP</general><general>American Society for Investigative Pathology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20041101</creationdate><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><author>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Blood Urea Nitrogen</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Cell Survival</topic><topic>Cisplatin - adverse effects</topic><topic>Cytokines - genetics</topic><topic>Cytokines - physiology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fibroblasts - metabolism</topic><topic>Genetic Predisposition to Disease</topic><topic>In Situ Nick-End Labeling</topic><topic>Inflammation</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Kidney - drug effects</topic><topic>Kidney - injuries</topic><topic>Kidney - pathology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - pathology</topic><topic>Oligonucleotides, Antisense - chemistry</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Original Research Paper</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Ribonucleases - metabolism</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawai, Hanayo</creatorcontrib><creatorcontrib>Sato, Waichi</creatorcontrib><creatorcontrib>Yuzawa, Yukio</creatorcontrib><creatorcontrib>Kosugi, Tomoki</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Takei, Yoshifumi</creatorcontrib><creatorcontrib>Kadomatsu, Kenji</creatorcontrib><creatorcontrib>Muramatsu, Takashi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawai, Hanayo</au><au>Sato, Waichi</au><au>Yuzawa, Yukio</au><au>Kosugi, Tomoki</au><au>Matsuo, Seiichi</au><au>Takei, Yoshifumi</au><au>Kadomatsu, Kenji</au><au>Muramatsu, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</atitle><jtitle>The American journal of pathology</jtitle><addtitle>Am J Pathol</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>165</volume><issue>5</issue><spage>1603</spage><epage>1612</epage><pages>1603-1612</pages><issn>0002-9440</issn><eissn>1525-2191</eissn><coden>AJPAA4</coden><abstract>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</abstract><cop>Bethesda, MD</cop><pub>Elsevier Inc</pub><pmid>15509530</pmid><doi>10.1016/S0002-9440(10)63417-7</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9440 |
ispartof | The American journal of pathology, 2004-11, Vol.165 (5), p.1603-1612 |
issn | 0002-9440 1525-2191 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618674 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; PubMed Central; EZB Electronic Journals Library |
subjects | Animals Antineoplastic Agents - pharmacology Apoptosis Biological and medical sciences Blood Urea Nitrogen Blotting, Northern Blotting, Western Cell Survival Cisplatin - adverse effects Cytokines - genetics Cytokines - physiology Enzyme-Linked Immunosorbent Assay Fibroblasts - metabolism Genetic Predisposition to Disease In Situ Nick-End Labeling Inflammation Investigative techniques, diagnostic techniques (general aspects) Kidney - drug effects Kidney - injuries Kidney - pathology Medical sciences Mice Mice, Transgenic Neutrophils - metabolism Neutrophils - pathology Oligonucleotides, Antisense - chemistry Oligonucleotides, Antisense - pharmacology Original Research Paper Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Ribonucleases - metabolism Time Factors Treatment Outcome |
title | Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T16%3A24%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20the%20Growth%20Factor%20Midkine%20Enhances%20Survival%20against%20Cisplatin-Induced%20Renal%20Damage&rft.jtitle=The%20American%20journal%20of%20pathology&rft.au=Kawai,%20Hanayo&rft.date=2004-11-01&rft.volume=165&rft.issue=5&rft.spage=1603&rft.epage=1612&rft.pages=1603-1612&rft.issn=0002-9440&rft.eissn=1525-2191&rft.coden=AJPAA4&rft_id=info:doi/10.1016/S0002-9440(10)63417-7&rft_dat=%3Cpubmed_cross%3E15509530%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15509530&rft_els_id=S0002944010634177&rfr_iscdi=true |